China Universal Asset Management Co., Ltd.

Position in AUTL — Autolus Therapeutics plc

CIK 1906594 SHANGHAI, F4

Position in AUTL

as of Jun 30, 2026 · filed Jul 24, 2026 Compact

Position Value

$51,080

+$1,957 QoQ

Shares Held

31,925

-10.3% QoQ

Ownership

0.012%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#46

of 84 holders

Holding Since

Sep 2022

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

China Universal Asset Management Co., Ltd. holds $180,189,557 across 240 Biotechnology names. AUTL ranks #199 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	48,265	$23,974,673
2	REGN	Regeneron Pharmaceuticals, Inc.	19,498	$12,157,782
3	ALNY	Alnylam Pharmaceuticals, Inc.	25,269	$7,606,727
4	RPRX	Royalty Pharma plc	120,547	$6,759,070
5	RVMD	Revolution Medicines, Inc.	33,835	$6,336,618
6	IONS	Ionis Pharmaceuticals Inc	76,302	$6,049,985
7	MRNA	Moderna, Inc.	63,149	$4,422,324
8	ARGX	Argenx SE	4,642	$4,306,708

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$51,080	31,925	-10.3%	Shares	Sole	2026-07-24
2026-03-31	$49,123	35,597	+8.9%	Shares	Sole	2026-04-28
2025-12-31	$65,047	32,687	-7.0%	Shares	Sole	2026-01-29
2025-09-30	$57,305	35,157	-12.7%	Shares	Sole	2025-11-10
2025-06-30	$91,822	40,273	+0.2%	Shares	Sole	2025-08-28
2025-03-31	$62,310	40,200	-5.1%	Shares	Sole	2025-04-30
2024-12-31	$99,510	42,345	+10.3%	Shares	Sole	2025-01-24
2024-09-30	$139,366	38,393	+63.8%	Shares	Sole	2024-10-25
2024-06-30	$81,550	23,434	-13.3%	Shares	Sole	2024-07-19
2024-03-31	$172,476	27,034	+66.2%	Shares	Sole	2024-05-21
2023-12-31	$104,733	16,263	+2900.6%	Shares	Sole	2024-05-22
2022-09-30	$1,159	542	—	Shares	Sole	2022-10-21
No filing history on record for this holder in this stock.